LATEST ANNOUNCEMENT

LCT Parkinson’s trial resumes patient recruitment

Living Cell Technologies Limited today announced that it has received the necessary regulatory approval to resume recruitment of the remaining three patients in the Phase I/IIa clinical trial of NTCELL®  in Parkinson’s disease.